CDER’s New Compliance Director Sklamberg Brings Experience On Compounding Issues
This article was originally published in The Pink Sheet Daily
Executive Summary
Howard Sklamberg, deputy associate commissioner in FDA’s Office of Regulatory Affairs, will take over as director of the Center for Drug Evaluation and Research’s Compliance Office in January; acting compliance director Ilisa Bernstein will resume her role as deputy director.
You may also be interested in...
Top US FDA Global Regulator Joins Major Law Firm's Health-Care Division
Howard Sklamberg, the former US FDA deputy commissioner for global regulatory operations and policy who left the agency in April, will now join the health-care practice at the law firm Akin Gump.
CDER Compliance Director Recused From Most Duties Due To Husband's Promotion
The HHS general counsel determines that to prevent potential conflicts of interest, Cynthia Schnedar must no longer handle substantive issues for compliance actions and policy.
CDER Compliance Director Recused From Most Duties Due To Husband's Promotion
The HHS general counsel determines that to prevent potential conflicts of interest, Cynthia Schnedar must no longer handle substantive issues for compliance actions and policy.